Valiant Laboratories IPO opens on Wednesday. Here are 10 things to know about the offer

economictimes.indiatimes.com:

IPO) of Valiant Laboratories will open for subscription on September 27. The issue closes on October 3.

The company's shares are expected to get listed on both the exchanges. Here are 10 things to know about the offer.

1. What is the business overview of Valiant Laboratories?
   Valiant Labs is an active pharmaceutical ingredient (API/bulk drug manufacturing company, with a focus on producing Paracetamol. APIs serve as raw materials for manufacturing finished dosage forms or formulations. Paracetamol is one of the most commonly taken analgesics worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO).
2. What is the industry overview of Valiant Laboratories?
   The pharmaceutical API industry in India is ranked third-largest globally in terms of volume. It is expected to clock a CAGR of 5-7% between fiscal 2023 and fiscal 2027, largely driven by the demand from domestic formulation manufacturers as well as export markets.
3. What is the size of the Valiant Laboratories IPO?
   The IPO is completely a fresh equity issue of Rs 1.08 crore shares.
4. What is the price band for Valiant Laboratories IPO?
   has set a price band of Rs 133-140 for its maiden public offer. At the upper price band, the company plans to raise Rs 152 crore. Investors can bid for a minimum of 105 shares in one lot and in multiples thereof.
5. What is the structure of Valiant Laboratories IPO?
   About 50% of the offer is set aside for qualified institutional buyers, 15% is reserved for non-institutional investors and 35% for retail investors.
6. How is the financial performance of Valiant Laboratories?
   The company's revenues grew 16% to Rs 339 crore in the fiscal year 2023, while net profit was marginally higher at Rs 28.9 crore,